ArticleProstate cancer and prostatic diseases2025

Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis "PCAN-23-0763R".

J W Yaxley et al.PubMed ↗Publisher ↗

No numbers read from the abstract.